ジェノタイピング市場：製品、技術、用途別-2025年～2030年の世界予測

ジェノタイピング市場は、2023年に207億1,000万米ドルと評価され、2024年には236億3,000万米ドルに達すると予測され、CAGR 14.14％で成長し、2030年には522億9,000万米ドルになると予測されています。

ジェノタイピングは、個人のDNA配列を調べることによって遺伝子構成の違いを決定するプロセスを包含します。これは、個別化医療、薬理ゲノミクス、バイオテクノロジー、農業生物学など、さまざまな用途に不可欠です。ジェノタイピングの必要性は、個人の遺伝子構成に基づいたオーダーメイドのヘルスケアソリューションを提供する精密医療に対する需要の高まりに起因しています。農業分野では、収量や耐病性を高める作物改良プログラムの考案に役立ちます。KEYWORD市場のバリューチェーンは、生物医学研究センターや病院から農業機関やバイオテクノロジー企業まで広がっています。市場成長は、ゲノム技術の進歩、DNAシーケンシングのコスト低下、早期診断・介入需要に拍車をかける遺伝性疾患の増加によって大きく左右されます。さらに、ヘルスケアコスト削減への注目の高まりが、疾病予防・管理におけるジェノタイピングソリューションを後押ししています。しかし、遺伝子データのプライバシーに関する倫理的懸念や高度なジェノタイピング技術の高コストといった課題が、市場浸透を遅らせています。主な成長機会は、ヘルスケアにおける診断精度や予測モデルを大幅に強化できる、実質的なデータ解釈のための人工知能の統合分野に存在します。特に低所得地域向けの、携帯可能で手頃な価格のジェノタイピングキットへの投資は、大きなビジネス成長の可能性を示しています。さらに、ハイテク企業と学術研究センターとのコラボレーションにより、リアルタイムのジェノタイピング機能を強化する革新的なソリューションが生まれる可能性があります。とはいえ、規制上のハードルや厳格な遺伝情報法への準拠は、対処すべき抑止要因として残っています。強固なプライバシー対策を確保しつつ、ゲノムデータへのオープンアクセスを促進することで、研究開発の新たな道が開ける可能性があります。したがって、技術革新とともに規制や倫理的懸念の解決に向けた徹底的なアプローチは、ジェノタイピング市場を大きな高みへと押し上げ、社会的・産業的な需要の高まりに合致させることができます。

市場力学：急速に進化するジェノタイピング市場の主要市場インサイトを公開

ジェノタイピング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 創薬および薬剤開発におけるジェノタイピングの重要性の高まり
  • パーキンソン病、ターナー症候群などの遺伝性疾患の有病率の増加
  • データ分析におけるバイオインフォマティクス・ソリューションの潜在的需要
• 市場抑制要因
  • 比較的高価な機器
• 市場機会
  • シーケンシングプロジェクトの世界の重要性の高まり
  • 農業分野での継続的な需要
• 市場の課題
  • 訓練を受けた専門家の不足とジェノタイピングにおけるデータ管理への懸念

ポーターの5つの力：ジェノタイピング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ジェノタイピング市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ジェノタイピング市場における外部からの影響の把握

外部マクロ環境要因は、ジェノタイピング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ジェノタイピング市場における競合情勢の把握

ジェノタイピング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスジェノタイピング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ジェノタイピング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ジェノタイピング市場における成功への道筋を描く

ジェノタイピング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品の発見と開発におけるジェノタイピングの重要性の高まり
    • パーキンソン病、ターナー症候群などの遺伝性疾患の増加
    • データ分析におけるバイオインフォマティクスソリューションの潜在的需要
  • 抑制要因
    • 比較的高価な機器
  • 機会
    • 世界のシークエンシングプロジェクトの重要性の高まり
    • 農業産業における継続的な需要
  • 課題
    • 訓練を受けた専門家の不足とジェノタイピングにおけるデータ管理に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ジェノタイピング市場：製品別

• 機器とサービス
• 試薬とキット

第7章 ジェノタイピング市場：技術別

• キャピラリー電気泳動
• 質量分析
• マイクロアレイ
• PCR
• シーケンシング

第8章 ジェノタイピング市場：用途別

• 診断
• 創薬

第9章 南北アメリカのジェノタイピング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のジェノタイピング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのジェノタイピング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agena Bioscience, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories Inc.
• Biofortuna Limited
• Danaher Corporation
• Eurofins Scientific SE
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Merck KGaA
• PerkinElmer, Inc.
• Precision Biomarker Resources, Inc.
• Qiagen NV
• Roche Diagnostics Corporation
• Sigma-Aldrich Corporation
• ThermoFisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. GENOTYPING MARKET RESEARCH PROCESS
• FIGURE 2. GENOTYPING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENOTYPING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENOTYPING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENOTYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENOTYPING MARKET DYNAMICS
• TABLE 7. GLOBAL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENOTYPING MARKET SIZE, BY INSTRUMENTS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENOTYPING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENOTYPING MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENOTYPING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENOTYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENOTYPING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENOTYPING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENOTYPING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENOTYPING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. CANADA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES GENOTYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. CHINA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. INDIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENOTYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ITALY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. POLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. QATAR GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM GENOTYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM GENOTYPING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM GENOTYPING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. GENOTYPING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. GENOTYPING MARKET, FPNV POSITIONING MATRIX, 2023

The Genotyping Market was valued at USD 20.71 billion in 2023, expected to reach USD 23.63 billion in 2024, and is projected to grow at a CAGR of 14.14%, to USD 52.29 billion by 2030.

Genotyping encompasses the process of determining differences in the genetic makeup by examining the individual's DNA sequence. It is crucial for various applications such as personalized medicine, pharmacogenomics, biotechnology, and agricultural biology. The necessity of genotyping stems from the increasing demand for precision medicine which caters to tailored healthcare solutions based on individual genetic makeups. In the agricultural sector, it helps devise crop improvement programs to enhance yield and disease resistance. The value chain of genotyping market extends from biomedical research centers and hospitals to agricultural institutes and biotechnology companies. Market growth is influenced significantly by advancements in genomic technologies, decreasing costs of DNA sequencing, and an increase in genetic diseases spurring demand for early diagnosis and intervention. Additionally, the growing focus on reducing healthcare costs fuels genotyping solutions in disease prevention and management. However, challenges such as ethical concerns regarding genetic data privacy and the high cost of advanced genotyping technologies slow down market penetration. Key growth opportunities exist in the areas of integrating artificial intelligence for substantial data interpretation, which can greatly enhance diagnostic accuracy and prediction models in healthcare. Investment in portable and affordable genotyping kits, especially for low-income regions, presents significant business growth potential. Moreover, collaborations between tech companies and academic research centers can yield innovative solutions enhancing real-time genotyping capabilities. Nevertheless, regulatory hurdles and compliance with stringent genetic information laws remain deterrents that need addressing. Fostering open access to genomic data while ensuring robust privacy measures could unlock new avenues of research and development. Therefore, a thorough approach towards resolving regulatory and ethical concerns along with technological innovation can propel the genotyping market to significant heights, aligning it with growing societal and industry-specific demands.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Market

The Genotyping Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing significance of genotyping in drug discovery and development
  • Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
  • Potential demand for bioinformatics solutions in data analysis
• Market Restraints
  • Relatively expensive equipment
• Market Opportunities
  • Emerging importance of sequencing projects globally
  • Ongoing demand in agriculture industries
• Market Challenges
  • Lack of trained professional and concerns in data management in genotyping

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Market

A detailed market share analysis in the Genotyping Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Market

A strategic analysis of the Genotyping Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Biofortuna Limited, Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA, PerkinElmer, Inc., Precision Biomarker Resources, Inc., Qiagen NV, Roche Diagnostics Corporation, Sigma-Aldrich Corporation, and ThermoFisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments & Services and Reagents & Kits.
• Based on Technology, market is studied across Capillary Electrophoresis, Mass Spectrometry, Microarray, PCR, and Sequencing.
• Based on Application, market is studied across Diagnostics and Drug Discovery.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing significance of genotyping in drug discovery and development
    • 5.1.1.2. Growing prevalence of genetic diseases such as Parkinson's, turner syndrome
    • 5.1.1.3. Potential demand for bioinformatics solutions in data analysis
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively expensive equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging importance of sequencing projects globally
    • 5.1.3.2. Ongoing demand in agriculture industries
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of trained professional and concerns in data management in genotyping
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genotyping Market, by Product

• 6.1. Introduction
• 6.2. Instruments & Services
• 6.3. Reagents & Kits

7. Genotyping Market, by Technology

• 7.1. Introduction
• 7.2. Capillary Electrophoresis
• 7.3. Mass Spectrometry
• 7.4. Microarray
• 7.5. PCR
• 7.6. Sequencing

8. Genotyping Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Drug Discovery

9. Americas Genotyping Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Genotyping Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Genotyping Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agena Bioscience, Inc.
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories Inc.
• 4. Biofortuna Limited
• 5. Danaher Corporation
• 6. Eurofins Scientific SE
• 7. F. Hoffmann-La Roche Ltd.
• 8. Illumina, Inc.
• 9. Merck KGaA
• 10. PerkinElmer, Inc.
• 11. Precision Biomarker Resources, Inc.
• 12. Qiagen NV
• 13. Roche Diagnostics Corporation
• 14. Sigma-Aldrich Corporation
• 15. ThermoFisher Scientific, Inc.